Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Vessels, Single-Use Equipment), Process (Cell Processing, Preservation, Distribution, QC), Cell type (T-Cells, Stem cells), Application (Cancer, CVD), End user - Global Forecast to 2029

Cell Therapy Technologies Market by Product (Media, Sera & Reagents, Vessels, Single-Use Equipment), Process (Cell Processing, Preservation, Distribution, QC), Cell type (T-Cells, Stem cells), Application (Cancer, CVD), End user - Global Forecast to 2029



The global cell therapy technologies market is projected to surpass USD 6.80 billion in 2029 from USD 4.03 billion in 2024, with a significant CAGR of 11.0%. This market is driven by advancements in regenerative medicine, the rising prevalence of chronic diseases, increasing investments in research and development, and innovations in gene editing tools, such as CRISPR. Regulatory support and government funding, alongside strategic collaborations between biotech firms and academic institutions, are propelling the development of novel cell therapies, subsequently driving the market growth.

“The T cells cell therapy technologies segment accounted for the largest share in 2023.”

The cell therapy technologies market is bifurcated into three primary categories based on cell type, that are T cells, stem cells, and other cells. The T cells segment dominated the share of the market in the year 2023 due to being crucial in advancing immunotherapies, especially CAR-T therapies spurring substantial investments and technological innovations in T-cell engineering and scalable manufacturing. Advancements in CRISPR technology, ex vivo expansion, and ""off-the-shelf"" allogeneic solutions all further help in advancing market offerings.

“By application, the cancer application segment accounted for the largest share in the cell therapy technologies market.”

The application segment in the cell therapy technologies market includes cancer, cardiovascular disease (CVD), orthopaedic disorders, autoimmune diseases, and other applications. The cancer application dominated the segment due to increasing prevalence of cancer globally and the rising demand for innovative, targeted therapies. Advancements in cell engineering, scalable manufacturing, and emerging applications in solid tumors further enhance the growth potential of this segment. It possesses a solid clinical pipeline, and the government initiatives are very supportive with regulatory approvals for the growth of the segment.

“North America: the largest share of the cell therapy technologies market”

By region, the market is segment into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. North America dominated the cell therapy technologies market in 2023 and likely continue to be dominant during the forecast period. North America dominates the cell therapy technologies market due to its robust healthcare infrastructure, significant investments in research and development, and the presence of key market players. The region benefits from strong regulatory support, with agencies like the FDA streamlining approvals for innovative therapies. High prevalence of chronic diseases, increasing demand for personalized medicine, and advanced manufacturing facilities further bolster regions dominance.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the cell therapy technologies market.

The primary interviews conducted for this report can be categorized as follows:

By Respondent: Supply Side- 70% and Demand Side 30%

By Designation: Managers - 45%, CXO & Directors - 30%, and Executives - 25%

By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5% and Middle East & Africa- 5%

Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), Sartorius AG (Germany), Agilent Technologies Inc. (US), Avantor, Inc. (US), Bio-Techne (US), Fresenius SE & Co KGAA (Germany), BD (US), Corning Incorporated (US), Terumo Corporation (Japan), GenScript (US), MaxCyte (US) and STEMCELL Technologies (Canada) are some of the major players operating in the cell therapy technologies market.

Research Coverage:

This research report categorizes the cell therapy technologies market product (media, sera, and reagents; cell engineering products; cell culture vessels; cell therapy equipment; systems & software; and other products), process (cell processing, cell preservation, cell distribution, cell handling, and process monitoring & quality control), cell type (T cells, stem cells, and other cells), application (cancer, cardiovascular disease (CVD), orthopedic disorders, autoimmune diseases, and other applications) end user (biopharmaceutical & biotechnology companies, CROs & CMOs, research institutes, and cell banks) and region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the cell therapy technologiess market. A detailed analysis of the key industry players has been done to provide insights into their business overview, products, key strategies, collaborations, partnerships, and agreements. New launches, collaborations and acquisitions, and recent developments associated with the cell therapy technologies market.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the cell therapy technologies and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (increased funding and investment in cell therapy, advancements in gene editing technologies, the development of automated cell processing systems, and regulatory support for fast-tracking therapies), restraints (manufacturing and logistical complexity), opportunities (personalized and off-the-shelf cell therapies, integration with digital technologies such as AI & ML) and Challenges (supply chain & cold chain management and manufacturing scalability & quality control).

Product Development/Innovation: Detailed insights on maintaining a comprehensive and innovative product portfolio offering for cell therapy technologies.

Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.

Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell therapy technologies market.

Competitive Assessment: Danaher Corporation (US), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (US), Lonza (Switzerland), Sartorius AG (Germany), and among others in the market.


Tables List
Table 1 Impact Analysis Of Supply-side And Demand-side Factors
Table 2 Cell Therapy Technologies Market: Risk Analysis
Table 3 Cell Therapy Technologies Market: Key Product Providers
Table 4 Cell Therapy Technologies Market: Key End Users
Table 5 Cell Therapy Technologies Market: Regulatory Bodies
Table 6 Average Selling Price Trend Of Cell Therapy Products,
By Key Player, 2022–2024
Table 7 Average Selling Price Trend Of Cell Therapy Equipment,
By Region, 2022–2024
Table 8 Key Patents In Cell Therapy Technologies Market, 2021–2024
Table 9 Import Volume For Hs Code 854330, 2019–2023 (Units)
Table 10 Export Volume For Hs Code 854330, 2019–2023 (Units)
Table 11 Cell Therapy Technologies Market:
Detailed List Of Conferences & Events
Table 12 North America: Regulatory Bodies, Government Agencies,
And Other Organizations
Table 13 Europe: List Of Regulatory Bodies, Government Agencies,
And Other Organizations
Table 14 Asia Pacific: List Of Regulatory Bodies, Government Agencies,
And Other Organizations
Table 15 Rest Of The World: List Of Regulatory Bodies, Government Agencies, And Other Organizations
Table 16 Cell Therapy Technologies Market: Porter’s Five Forces Analysis
Table 17 Influence Of Stakeholders On Buying Process For Top Four End Users
Table 18 Key Buying Criteria For Cell Therapy Technologies Products,
By End User
Table 19 Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 20 Cell Therapy Media, Sera, And Reagents Market, By Region,
2022–2029 (Usd Million)
Table 21 North America: Cell Therapy Media, Sera, And Reagents Market,
By Country, 2022–2029 (Usd Million)
Table 22 Europe: Cell Therapy Media, Sera, And Reagents Market,
By Country, 2022–2029 (Usd Million)
Table 23 Asia Pacific: Cell Therapy Media, Sera, And Reagents Market,
By Country, 2022–2029 (Usd Million)
Table 24 Latin America: Cell Therapy Media, Sera, And Reagents Market,
By Country, 2022–2029 (Usd Million)
Table 25 Middle East: Cell Therapy Media, Sera, And Reagents Market,
By Region, 2022–2029 (Usd Million)
Table 26 Gcc Countries: Cell Therapy Media, Sera, And Reagents Market,
By Country, 2022–2029 (Usd Million)
Table 27 Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 28 Cell Therapy Equipment Market, By Region, 2022–2029 (Usd Million)
Table 29 North America: Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 30 Europe: Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 31 Asia Pacific: Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 32 Latin America: Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 33 Middle East: Cell Therapy Equipment Market, By Region,
2022–2029 (Usd Million)
Table 34 Gcc Countries: Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 35 Cell Processing Equipment Market, By Region, 2022–2029 (Usd Million)
Table 36 North America: Cell Processing Equipment Market, By Country,
2022–2029 (Usd Million)
Table 37 Europe: Cell Processing Equipment Market, By Country,
2022–2029 (Usd Million)
Table 38 Asia Pacific: Cell Processing Equipment Market, By Country,
2022–2029 (Usd Million)
Table 39 Latin America: Cell Processing Equipment Market, By Country,
2022–2029 (Usd Million)
Table 40 Middle East: Cell Processing Equipment Market, By Region,
2022–2029 (Usd Million)
Table 41 Gcc Countries: Cell Processing Equipment Market, By Country,
2022–2029 (Usd Million)
Table 42 Single-use Equipment Market, By Region, 2022–2029 (Usd Million)
Table 43 North America: Single-use Equipment Market, By Country,
2022–2029 (Usd Million)
Table 44 Europe: Single-use Equipment Market, By Country,
2022–2029 (Usd Million)
Table 45 Asia Pacific: Single-use Equipment Market, By Country,
2022–2029 (Usd Million)
Table 46 Latin America: Single-use Equipment Market, By Country,
2022–2029 (Usd Million)
Table 47 Middle East: Single-use Equipment Market, By Region,
2022–2029 (Usd Million)
Table 48 Gcc Countries: Single-use Equipment Market, By Country,
2022–2029 (Usd Million)
Table 49 Other Cell Therapy Equipment Market, By Region,
2022–2029 (Usd Million)
Table 50 North America: Other Cell Therapy Equipment Market, By Country, 2022–2029 (Usd Million)
Table 51 Europe: Other Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 52 Asia Pacific: Other Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 53 Latin America: Other Cell Therapy Equipment Market, By Country,
2022–2029 (Usd Million)
Table 54 Middle East: Other Cell Therapy Equipment Market, By Region,
2022–2029 (Usd Million)
Table 55 Gcc Countries: Other Cell Therapy Equipment Market, By Country, 2022–2029 (Usd Million)
Table 56 Cell Therapy Systems & Software, By Company
Table 57 Cell Therapy Systems & Software Market, By Region,
2022–2029 (Usd Million)
Table 58 North America: Cell Therapy Systems & Software Market, By Country, 2022–2029 (Usd Million)
Table 59 Europe: Cell Therapy Systems & Software Market, By Country,
2022–2029 (Usd Million)
Table 60 Asia Pacific: Cell Therapy Systems & Software Market, By Country, 2022–2029 (Usd Million)
Table 61 Latin America: Cell Therapy Systems & Software Market, By Country, 2022–2029 (Usd Million)
Table 62 Middle East: Cell Therapy Systems & Software Market, By Region, 2022–2029 (Usd Million)
Table 63 Gcc Countries: Cell Therapy Systems & Software Market, By Country, 2022–2029 (Usd Million)
Table 64 Cell Culture Vessels Market, By Region, 2022–2029 (Usd Million)
Table 65 North America: Cell Culture Vessels Market, By Country,
2022–2029 (Usd Million)
Table 66 Europe: Cell Culture Vessels Market, By Country,
2022–2029 (Usd Million)
Table 67 Asia Pacific: Cell Culture Vessels Market, By Country,
2022–2029 (Usd Million)
Table 68 Latin America: Cell Culture Vessels Market, By Country,
2022–2029 (Usd Million)
Table 69 Middle East: Cell Culture Vessels Market, By Region,
2022–2029 (Usd Million)
Table 70 Gcc Countries: Cell Culture Vessels Market, By Country,
2022–2029 (Usd Million)
Table 71 Cell Engineering Products Offered, By Company
Table 72 Cell Engineering Products Market, By Region, 2022–2029 (Usd Million)
Table 73 North America: Cell Engineering Products Market, By Country,
2022–2029 (Usd Million)
Table 74 Europe: Cell Engineering Products Market, By Country,
2022–2029 (Usd Million)
Table 75 Asia Pacific: Cell Engineering Products Market, By Country,
2022–2029 (Usd Million)
Table 76 Latin America: Cell Engineering Products Market, By Country,
2022–2029 (Usd Million)
Table 77 Middle East: Cell Engineering Products Market, By Region,
2022–2029 (Usd Million)
Table 78 Gcc Countries: Cell Engineering Products Market, By Country,
2022–2029 (Usd Million)
Table 79 Other Cell Therapy Products Market, By Region,
2022–2029 (Usd Million)
Table 80 North America: Other Cell Therapy Products Market, By Country, 2022–2029 (Usd Million)
Table 81 Europe: Other Cell Therapy Products Market, By Country,
2022–2029 (Usd Million)
Table 82 Asia Pacific: Other Cell Therapy Products Market, By Country,
2022–2029 (Usd Million)
Table 83 Latin America: Other Cell Therapy Products Market, By Country,
2022–2029 (Usd Million)
Table 84 Middle East: Other Cell Therapy Products Market, By Region,
2022–2029 (Usd Million)
Table 85 Gcc Countries: Other Cell Therapy Products Market, By Country, 2022–2029 (Usd Million)
Table 86 Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 87 Cell Therapy Technologies Market For Cell Processing, By Type,
2022–2029 (Usd Million)
Table 88 Cell Therapy Technologies Market For Cell Processing, By Region, 2022–2029 (Usd Million)
Table 89 North America: Cell Therapy Technologies Market For
Cell Processing, By Country, 2022–2029 (Usd Million)
Table 90 Europe: Cell Therapy Technologies Market For Cell Processing,
By Country, 2022–2029 (Usd Million)
Table 91 Asia Pacific: Cell Therapy Technologies Market For Cell Processing,
By Country, 2022–2029 (Usd Million)
Table 92 Latin America: Cell Therapy Technologies Market For Cell Processing, By Country, 2022–2029 (Usd Million)
Table 93 Middle East: Cell Therapy Technologies Market For Cell Processing, By Region, 2022–2029 (Usd Million)
Table 94 Gcc Countries: Cell Therapy Technologies Market For Cell Processing, By Country, 2022–2029 (Usd Million)
Table 95 Cell Therapy Technologies Market For Cell Expansion, By Region, 2022–2029 (Usd Million)
Table 96 Cell Therapy Technologies Market For Cell Expansion, By Country, 2022–2029 (Usd Million)
Table 97 Europe: Cell Therapy Technologies Market For Cell Expansion,
By Country, 2022–2029 (Usd Million)
Table 98 Asia Pacific: Cell Therapy Technologies Market For Cell Expansion,
By Country, 2022–2029 (Usd Million)
Table 99 Latin America: Cell Therapy Technologies Market For Cell Expansion, By Country, 2022–2029 (Usd Million)
Table 100 Middle East: Cell Therapy Technologies Market For Cell Expansion,
By Region, 2022–2029 (Usd Million)
Table 101 Gcc Countries: Cell Therapy Technologies Market For Cell Expansion, By Country, 2022–2029 (Usd Million)
Table 102 Cell Therapy Technologies Market For Cell Isolation, By Region,
2022–2029 (Usd Million)
Table 103 North America: Cell Therapy Technologies Market For Cell Isolation, By Country, 2022–2029 (Usd Million)
Table 104 Europe: Cell Therapy Technologies Market For Cell Isolation,
By Country, 2022–2029 (Usd Million)
Table 105 Asia Pacific: Cell Therapy Technologies Market For Cell Isolation,
By Country, 2022–2029 (Usd Million)
Table 106 Latin America: Cell Therapy Technologies Market For Cell Isolation,
By Country, 2022–2029 (Usd Million)
Table 107 Middle East: Cell Therapy Technologies Market For Cell Isolation,
By Region, 2022–2029 (Usd Million)
Table 108 Gcc Countries: Cell Therapy Technologies Market For Cell Isolation, By Country, 2022–2029 (Usd Million)
Table 109 Cell Therapy Technologies Market For Cell Characterization, By Region, 2022–2029 (Usd Million)
Table 110 Cell Therapy Technologies Market For Cell Characterization,
By Country, 2022–2029 (Usd Million)
Table 111 Europe: Cell Therapy Technologies Market For Cell Characterization, By Country, 2022–2029 (Usd Million)
Table 112 Asia Pacific: Cell Therapy Technologies Market For Cell Characterization, By Country, 2022–2029 (Usd Million)
Table 113 Latin America: Cell Therapy Technologies Market For Cell Characterization, By Country, 2022–2029 (Usd Million)
Table 114 Middle East: Cell Therapy Technologies Market For Cell Characterization, By Region, 2022–2029 (Usd Million)
Table 115 Gcc Countries: Cell Therapy Technologies Market For Cell Characterization, By Country, 2022–2029 (Usd Million)
Table 116 Cell Therapy Technologies Market For Cell Collection, By Region, 2022–2029 (Usd Million)
Table 117 North America: Cell Therapy Technologies Market For
Cell Collection, By Country, 2022–2029 (Usd Million)
Table 118 Europe: Cell Therapy Technologies Market For Cell Collection,
By Country, 2022–2029 (Usd Million)
Table 119 Asia Pacific: Cell Therapy Technologies Market For Cell Collection,
By Country, 2022–2029 (Usd Million)
Table 120 Latin America: Cell Therapy Technologies Market For Cell Collection, By Country, 2022–2029 (Usd Million)
Table 121 Middle East: Cell Therapy Technologies Market For Cell Collection,
By Region, 2022–2029 (Usd Million)
Table 122 Gcc Countries: Cell Therapy Technologies Market For Cell Collection, By Country, 2022–2029 (Usd Million)
Table 123 Cell Therapy Technologies Market For Cell Preservation, By Region, 2022–2029 (Usd Million)
Table 124 Cell Therapy Technologies Market For Cell Preservation, By Country, 2022–2029 (Usd Million)
Table 125 Europe: Cell Therapy Technologies Market For Cell Preservation,
By Country, 2022–2029 (Usd Million)
Table 126 Asia Pacific: Cell Therapy Technologies Market For Cell Preservation, By Country, 2022–2029 (Usd Million)
Table 127 Latin America: Cell Therapy Technologies Market For Cell Preservation, By Country, 2022–2029 (Usd Million)
Table 128 Middle East: Cell Therapy Technologies Market For
Cell Preservation, By Region, 2022–2029 (Usd Million)
Table 129 Gcc Countries: Cell Therapy Technologies Market For Cell Preservation, By Country, 2022–2029 (Usd Million)
Table 130 Cell Therapy Technologies Market For Process Monitoring &
Quality Control, By Region, 2022–2029 (Usd Million)
Table 131 Cell Therapy Technologies Market For Process Monitoring &
Quality Control, By Country, 2022–2029 (Usd Million)
Table 132 Europe: Cell Therapy Technologies Market For Process
Monitoring & Quality Control, By Country, 2022–2029 (Usd Million)
Table 133 Asia Pacific: Cell Therapy Technologies Market For Process Monitoring & Quality Control, By Country, 2022–2029 (Usd Million)
Table 134 Latin America: Cell Therapy Technologies Market For Process Monitoring & Quality Control, By Country, 2022–2029 (Usd Million)
Table 135 Middle East: Cell Therapy Technologies Market For Process Monitoring & Quality Control, By Region, 2022–2029 (Usd Million)
Table 136 Gcc Countries: Cell Therapy Technologies Market For Process Monitoring & Quality Control, By Country, 2022–2029 (Usd Million)
Table 137 Cell Therapy Technologies Market For Cell Handling, By Region,
2022–2029 (Usd Million)
Table 138 Cell Therapy Technologies Market For Cell Handling, By Country, 2022–2029 (Usd Million)
Table 139 Europe: Cell Therapy Technologies Market For Cell Handling,
By Country, 2022–2029 (Usd Million)
Table 140 Asia Pacific: Cell Therapy Technologies Market For Cell Handling,
By Country, 2022–2029 (Usd Million)
Table 141 Latin America: Cell Therapy Technologies Market For Cell Handling,
By Country, 2022–2029 (Usd Million)
Table 142 Middle East: Cell Therapy Technologies Market For Cell Handling,
By Region, 2022–2029 (Usd Million)
Table 143 Gcc Countries: Cell Therapy Technologies Market For Cell Handling, By Country, 2022–2029 (Usd Million)
Table 144 Cell Therapy Technologies Market For Cell Distribution, By Region, 2022–2029 (Usd Million)
Table 145 Cell Therapy Technologies Market For Cell Distribution, By Country, 2022–2029 (Usd Million)
Table 146 Europe: Cell Therapy Technologies Market For
Cell Distribution, By Country, 2022–2029 (Usd Million)
Table 147 Asia Pacific: Cell Therapy Technologies Market For
Cell Distribution, By Country, 2022–2029 (Usd Million)
Table 148 Latin America: Cell Therapy Technologies Market For
Cell Distribution, By Country, 2022–2029 (Usd Million)
Table 149 Middle East: Cell Therapy Technologies Market For
Cell Distribution, By Region, 2022–2029 (Usd Million)
Table 150 Gcc Countries: Cell Therapy Technologies Market For
Cell Distribution, By Country, 2022–2029 (Usd Million)
Table 151 Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 152 T-cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 153 North America: T-cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 154 Europe: T-cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 155 Asia Pacific: T-cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 156 Latin America: T-cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 157 Middle East: T-cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 158 Gcc Countries: T-cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 159 Stem Cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 160 North America: Stem Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 161 Europe: Stem Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 162 Asia Pacific: Stem Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 163 Latin America: Stem Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 164 Middle East: Stem Cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 165 Gcc Countries: Stem Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 166 Other Cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 167 North America: Other Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 168 Europe: Other Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 169 Asia Pacific: Other Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 170 Latin America: Other Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 171 Middle East: Other Cell Therapy Technologies Market, By Region, 2022–2029 (Usd Million)
Table 172 Gcc Countries: Other Cell Therapy Technologies Market, By Country, 2022–2029 (Usd Million)
Table 173 Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 174 Cell Therapy Technologies Market For Cancer, By Region,
2022–2029 (Usd Million)
Table 175 North America: Cell Therapy Technologies Market For Cancer,
By Country, 2022–2029 (Usd Million)
Table 176 Europe: Cell Therapy Technologies Market For Cancer, By Country, 2022–2029 (Usd Million)
Table 177 Asia Pacific: Cell Therapy Technologies Market For Cancer, By Country, 2022–2029 (Usd Million)
Table 178 Latin America: Cell Therapy Technologies Market For Cancer,
By Country, 2022–2029 (Usd Million)
Table 179 Middle East: Cell Therapy Technologies Market For Cancer, By Region, 2022–2029 (Usd Million)
Table 180 Gcc Countries: Cell Therapy Technologies Market For Cancer,
By Country, 2022–2029 (Usd Million)
Table 181 Cell Therapy Technologies Market For Cardiovascular Disease,
By Region, 2022–2029 (Usd Million)
Table 182 North America: Cell Therapy Technologies Market For
Cardiovascular Disease, By Country, 2022–2029 (Usd Million)
Table 183 Europe: Cell Therapy Technologies Market For
Cardiovascular Disease, By Country, 2022–2029 (Usd Million)
Table 184 Asia Pacific: Cell Therapy Technologies Market For
Cardiovascular Disease, By Country, 2022–2029 (Usd Million)
Table 185 Latin America: Cell Therapy Technologies Market For
Cardiovascular Disease, By Country, 2022–2029 (Usd Million)
Table 186 Middle East: Cell Therapy Technologies Market For
Cardiovascular Disease, By Region, 2022–2029 (Usd Million)
Table 187 Gcc Countries: Cell Therapy Technologies Market For
Cardiovascular Disease, By Country, 2022–2029 (Usd Million)
Table 188 Cell Therapy Technologies Market For Orthopedic Disorders,
By Region, 2022–2029 (Usd Million)
Table 189 North America: Cell Therapy Technologies Market For
Orthopedic Disorders, By Country, 2022–2029 (Usd Million)
Table 190 Europe: Cell Therapy Technologies Market For
Orthopedic Disorders, By Country, 2022–2029 (Usd Million)
Table 191 Asia Pacific: Cell Therapy Technologies Market For
Orthopedic Disorders, By Country, 2022–2029 (Usd Million)
Table 192 Latin America: Cell Therapy Technologies Market For
Orthopedic Disorders, By Country, 2022–2029 (Usd Million)
Table 193 Middle East: Cell Therapy Technologies Market For
Orthopedic Disorders, By Region, 2022–2029 (Usd Million)
Table 194 Gcc Countries: Cell Therapy Technologies Market For
Orthopedic Disorders, By Country, 2022–2029 (Usd Million)
Table 195 Cell Therapy Technologies Market For Autoimmune Diseases,
By Region, 2022–2029 (Usd Million)
Table 196 North America: Cell Therapy Technologies Market For
Autoimmune Diseases, By Country, 2022–2029 (Usd Million)
Table 197 Europe: Cell Therapy Technologies Market For
Autoimmune Diseases, By Country, 2022–2029 (Usd Million)
Table 198 Asia Pacific: Cell Therapy Technologies Market For
Autoimmune Diseases, By Country, 2022–2029 (Usd Million)
Table 199 Latin America: Cell Therapy Technologies Market For
Autoimmune Diseases, By Country, 2022–2029 (Usd Million)
Table 200 Middle East: Cell Therapy Technologies Market For
Autoimmune Diseases, By Region, 2022–2029 (Usd Million)
Table 201 Gcc Countries: Cell Therapy Technologies Market For
Autoimmune Diseases, By Country, 2022–2029 (Usd Million)
Table 202 Cell Therapy Technologies Market For Other Applications,
By Region, 2022–2029 (Usd Million)
Table 203 North America: Cell Therapy Technologies Market For
Other Applications, By Country, 2022–2029 (Usd Million)
Table 204 Europe: Cell Therapy Technologies Market For
Other Applications, By Country, 2022–2029 (Usd Million)
Table 205 Asia Pacific: Cell Therapy Technologies Market For
Other Applications, By Country, 2022–2029 (Usd Million)
Table 206 Latin America: Cell Therapy Technologies Market For
Other Applications, By Country, 2022–2029 (Usd Million)
Table 207 Middle East: Cell Therapy Technologies Market For
Other Applications, By Region, 2022–2029 (Usd Million)
Table 208 Gcc Countries: Cell Therapy Technologies Market For
Other Applications, By Country, 2022–2029 (Usd Million)
Table 209 Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 210 Cell Therapy Technologies Market For Biopharmaceutical
& Biotechnology Companies, By Region, 2022–2029 (Usd Million)
Table 211 North America: Cell Therapy Technologies Market For Biopharmaceutical & Biotechnology Companies, By Country,
2022–2029 (Usd Million)
Table 212 Europe: Cell Therapy Technologies Market For Biopharmaceutical
& Biotechnology Companies, By Country, 2022–2029 (Usd Million)
Table 213 Asia Pacific: Cell Therapy Technologies Market For Biopharmaceutical & Biotechnology Companies, By Country, 2022–2029 (Usd Million)
Table 214 Latin America: Cell Therapy Technologies Market For Biopharmaceutical & Biotechnology Companies, By Country,
2022–2029 (Usd Million)
Table 215 Middle East: Cell Therapy Technologies Market For Biopharmaceutical & Biotechnology Companies, By Region, 2022–2029 (Usd Million)
Table 216 Gcc Countries: Cell Therapy Technologies Market For Biopharmaceutical & Biotechnology Companies, By Country,
2022–2029 (Usd Million)
Table 217 Cell Therapy Technologies Market For Cros & Cmos, By Region,
2022–2029 (Usd Million)
Table 218 North America: Cell Therapy Technologies Market For Cros & Cmos,
By Country, 2022–2029 (Usd Million)
Table 219 Europe: Cell Therapy Technologies Market For Cros & Cmos,
By Country, 2022–2029 (Usd Million)
Table 220 Asia Pacific: Cell Therapy Technologies Market For Cros & Cmos,
By Country, 2022–2029 (Usd Million)
Table 221 Latin America: Cell Therapy Technologies Market For Cros & Cmos,
By Country, 2022–2029 (Usd Million)
Table 222 Middle East: Cell Therapy Technologies Market For Cros & Cmos,
By Region, 2022–2029 (Usd Million)
Table 223 Gcc Countries: Cell Therapy Technologies Market For Cros & Cmos,
By Country, 2022–2029 (Usd Million)
Table 224 Cell Therapy Technologies Market For Research Institutes,
By Region, 2022–2029 (Usd Million)
Table 225 North America: Cell Therapy Technologies Market For
Research Institutes, By Country, 2022–2029 (Usd Million)
Table 226 Europe: Cell Therapy Technologies Market For
Research Institutes, By Country, 2022–2029 (Usd Million)
Table 227 Asia Pacific: Cell Therapy Technologies Market For
Research Institutes, By Country, 2022–2029 (Usd Million)
Table 228 Latin America: Cell Therapy Technologies Market For
Research Institutes, By Country, 2022–2029 (Usd Million)
Table 229 Middle East: Cell Therapy Technologies Market For
Research Institutes, By Region, 2022–2029 (Usd Million)
Table 230 Gcc Countries: Cell Therapy Technologies Market For
Research Institutes, By Country, 2022–2029 (Usd Million)
Table 231 Cell Therapy Technologies Market For Cell Banks, By Region,
2022–2029 (Usd Million)
Table 232 North America: Cell Therapy Technologies Market For Cell Banks,
By Country, 2022–2029 (Usd Million)
Table 233 Europe: Cell Therapy Technologies Market For Cell Banks,
By Country, 2022–2029 (Usd Million)
Table 234 Asia Pacific: Cell Therapy Technologies Market For Cell Banks,
By Country, 2022–2029 (Usd Million)
Table 235 Latin America: Cell Therapy Technologies Market For Cell Banks,
By Country, 2022–2029 (Usd Million)
Table 236 Middle East: Cell Therapy Technologies Market For Cell Banks,
By Region, 2022–2029 (Usd Million)
Table 237 Gcc Countries: Cell Therapy Technologies Market For Cell Banks,
By Country, 2022–2029 (Usd Million)
Table 238 Cell Therapy Technologies Market, By Region, 2022–2029 (Usd Million)
Table 239 North America: Key Macroindicators
Table 240 North America: Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 241 North America: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 242 North America: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 243 North America: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 244 North America: Cell Therapy Technologies Market For
Cell Processing, By Type, 2022–2029 (Usd Million)
Table 245 North America: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 246 North America: Cell Therapy Technologies Market, By Application, 2022–2029 (Usd Million)
Table 247 North America: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 248 Us: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 249 Us: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 250 Us: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 251 Us: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 252 Us: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 253 Us: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 254 Us: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 255 Canada: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 256 Canada: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 257 Canada: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 258 Canada: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 259 Canada: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 260 Canada: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 261 Canada: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 262 Europe: Key Macroindicators
Table 263 Europe: Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 264 Europe: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 265 Europe: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 266 Europe: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 267 Europe: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 268 Europe: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 269 Europe: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 270 Europe: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 271 Germany: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 272 Germany: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 273 Germany: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 274 Germany: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 275 Germany: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 276 Germany: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 277 Germany: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 278 Uk: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 279 Uk: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 280 Uk: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 281 Uk: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 282 Uk: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 283 Uk: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 284 Uk: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 285 France: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 286 France: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 287 France: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 288 France: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 289 France: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 290 France: Cell Therapy Technolo gies Market, By Application,
2022–2029 (Usd Million)
Table 291 France: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 292 Italy: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 293 Italy: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 294 Italy: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 295 Italy: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 296 Italy: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 297 Italy: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 298 Italy: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 299 Spain: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 300 Spain: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 301 Spain: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 302 Spain: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 303 Spain: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 304 Spain: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 305 Spain: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 306 Rest Of Europe: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 307 Rest Of Europe: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 308 Rest Of Europe: Cell Therapy Technologies Market, By Process, 2022–2029 (Usd Million)
Table 309 Rest Of Europe: Cell Therapy Technologies Market For
Cell Processing, By Type, 2022–2029 (Usd Million)
Table 310 Rest Of Europe: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 311 Rest Of Europe: Cell Therapy Technologies Market, By Application, 2022–2029 (Usd Million)
Table 312 Rest Of Europe: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 313 Asia Pacific: Key Macroindicators
Table 314 Asia Pacific: Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 315 Asia Pacific: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 316 Asia Pacific: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 317 Asia Pacific: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 318 Asia Pacific: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 319 Asia Pacific: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 320 Asia Pacific: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 321 Asia Pacific: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 322 China: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 323 China: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 324 China: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 325 China: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 326 China: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 327 China: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 328 China: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 329 Japan: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 330 Japan: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 331 Japan: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 332 Japan: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 333 Japan: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 334 Japan: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 335 Japan: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 336 India: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 337 India: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 338 India: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 339 India: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 340 India: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 341 India: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 342 India: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 343 Australia: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 344 Australia: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 345 Australia: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 346 Australia: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 347 Australia: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 348 Australia: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 349 Australia: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 350 South Korea: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 351 South Korea: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 352 South Korea: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 353 South Korea: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 354 South Korea: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 355 South Korea: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 356 South Korea: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 357 Rest Of Asia Pacific: Cell Therapy Technologies Market, By Product, 2022–2029 (Usd Million)
Table 358 Rest Of Asia Pacific: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 359 Rest Of Asia Pacific: Cell Therapy Technologies Market, By Process, 2022–2029 (Usd Million)
Table 360 Rest Of Asia Pacific: Cell Therapy Technologies Market For
Cell Processing, By Type, 2022–2029 (Usd Million)
Table 361 Rest Of Asia Pacific: Cell Therapy Technologies Market, By Cell Type, 2022–2029 (Usd Million)
Table 362 Rest Of Asia Pacific: Cell Therapy Technologies Market, By Application, 2022–2029 (Usd Million)
Table 363 Rest Of Asia Pacific: Cell Therapy Technologies Market, By End User, 2022–2029 (Usd Million)
Table 364 Latin America: Key Macroindicators
Table 365 Latin America: Cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 366 Latin America: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 367 Latin America: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 368 Latin America: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 369 Latin America: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 370 Latin America: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 371 Latin America: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 372 Latin America: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 373 Brazil: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 374 Brazil: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 375 Brazil: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 376 Brazil: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 377 Brazil: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 378 Brazil: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 379 Brazil: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 380 Mexico: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 381 Mexico: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 382 Mexico: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 383 Mexico: Cell Therapy Technologies Market For Cell Processing,
By Type, 2022–2029 (Usd Million)
Table 384 Mexico: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 385 Mexico: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 386 Mexico: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 387 Rest Of Latin America: Cell Therapy Technologies Market, By Product, 2022–2029 (Usd Million)
Table 388 Rest Of Latin America: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 389 Rest Of Latin America: Cell Therapy Technologies Market, By Process, 2022–2029 (Usd Million)
Table 390 Rest Of Latin America: Cell Therapy Technologies Market For
Cell Processing, By Type, 2022–2029 (Usd Million)
Table 391 Rest Of Latin America: Cell Therapy Technologies Market,
By Cell Type, 2022–2029 (Usd Million)
Table 392 Rest Of Latin America: Cell Therapy Technologies Market,
By Application, 2022–2029 (Usd Million)
Table 393 Rest Of Latin America: Cell Therapy Technologies Market,
By End User, 2022–2029 (Usd Million)
Table 394 Middle East: Key Macroindicators
Table 395 Middle East: Cell Therapy Technologies Market, By Region,
2022–2029 (Usd Million)
Table 396 Middle East: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 397 Middle East: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 398 Middle East: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 399 Middle East: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 400 Middle East: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 401 Middle East: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 402 Middle East: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 403 Gcc Countries: Cell Therapy Technologies Market, By Country,
2022–2029 (Usd Million)
Table 404 Gcc Countries: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 405 Gcc Countries: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 406 Gcc Countries: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 407 Gcc Countries: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 408 Gcc Countries: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 409 Gcc Countries: Cell Therapy Technologies Market, By Application, 2022–2029 (Usd Million)
Table 410 Gcc Countries: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 411 Saudi Arabia: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 412 Saudi Arabia: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 413 Saudi Arabia: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 414 Saudi Arabia: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 415 Saudi Arabia: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 416 Saudi Arabia: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 417 Saudi Arabia: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 418 Uae: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 419 Uae: Cell Therapy Equipment Market, By Type, 2022–2029 (Usd Million)
Table 420 Uae: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 421 Uae: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 422 Uae: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 423 Uae: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 424 Uae: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 425 Rest Of Gcc Countries: Cell Therapy Technologies Market,
By Product, 2022–2029 (Usd Million)
Table 426 Rest Of Gcc Countries: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 427 Rest Of Gcc Countries: Cell Therapy Technologies Market,
By Process, 2022–2029 (Usd Million)
Table 428 Rest Of Gcc Countries: Cell Therapy Technologies Market For
Cell Processing, By Type, 2022–2029 (Usd Million)
Table 429 Rest Of Gcc Countries: Cell Therapy Technologies Market,
By Cell Type, 2022–2029 (Usd Million)
Table 430 Rest Of Gcc Countries: Cell Therapy Technologies Market,
By Application, 2022–2029 (Usd Million)
Table 431 Rest Of Gcc Countries: Cell Therapy Technologies Market,
By End User, 2022–2029 (Usd Million)
Table 432 Rest Of Middle East: Cell Therapy Technologies Market, By Product, 2022–2029 (Usd Million)
Table 433 Rest Of Middle East: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 434 Rest Of Middle East: Cell Therapy Technologies Market, By Process, 2022–2029 (Usd Million)
Table 435 Rest Of Middle East: Cell Therapy Technologies Market For
Cell Processing, By Type, 2022–2029 (Usd Million)
Table 436 Rest Of Middle East: Cell Therapy Technologies Market, By Cell Type, 2022–2029 (Usd Million)
Table 437 Rest Of Middle East: Cell Therapy Technologies Market, By Application, 2022–2029 (Usd Million)
Table 438 Rest Of Middle East: Cell Therapy Technologies Market, By End User, 2022–2029 (Usd Million)
Table 439 Africa: Key Macroindicators
Table 440 Africa: Cell Therapy Technologies Market, By Product,
2022–2029 (Usd Million)
Table 441 Africa: Cell Therapy Equipment Market, By Type,
2022–2029 (Usd Million)
Table 442 Africa: Cell Therapy Technologies Market, By Process,
2022–2029 (Usd Million)
Table 443 Africa: Cell Therapy Technologies Market For Cell Processing, By Type, 2022–2029 (Usd Million)
Table 444 Africa: Cell Therapy Technologies Market, By Cell Type,
2022–2029 (Usd Million)
Table 445 Africa: Cell Therapy Technologies Market, By Application,
2022–2029 (Usd Million)
Table 446 Africa: Cell Therapy Technologies Market, By End User,
2022–2029 (Usd Million)
Table 447 Overview Of Strategies Deployed By
Key Manufacturing Companies, 2021–2023
Table 448 Cell Therapy Technologies Market: Degree Of Competition
Table 449 Cell Therapy Technologies Market: Region Footprint
Table 450 Cell Therapy Technologies Market: Product Footprint
Table 451 Cell Therapy Technologies Market: Process Footprint
Table 452 Cell Therapy Technologies Market: Cell Type Footprint
Table 453 Cell Therapy Technologies Market: Application Footprint
Table 454 Cell Therapy Technologies Market: Detailed List Of Key Startups/Smes
Table 455 Cell Therapy Technologies Market:
Competitive Benchmarking Of Startups/Smes
Table 456 Cell Therapy Technologies Market:
Product Launches, January 2021–november 2024
Table 457 Cell Therapy Technologies Market:
Deals, January 2021– November 2024
Table 458 Cell Therapy Technologies Market: Expansions, January 2021– November 2024
Table 459 Danaher Corporation: Company Overview
Table 460 Danaher Corporation: Products Offered
Table 461 Danaher Corporation: Product Launches, January 2021– October 2024
Table 462 Danaher Corporation: Deals, January 2021– October 2024
Table 463 Danaher Corporation: Expansions, January 2021– October 2024
Table 464 Merck Kgaa: Company Overview
Table 465 Merck Kgaa: Products Offered
Table 466 Merck Kgaa: Deals, January 2021–september 2024
Table 467 Merck Kgaa: Expansions, January 2021–september 2024
Table 468 Thermo Fisher Scientific Inc: Company Overview
Table 469 Thermo Fisher Scientific Inc: Products Offered
Table 470 Thermo Fisher Scientific Inc:
Product Launches, January 2021–september 2024
Table 471 Thermo Fisher Scientific Inc: Deals, January 2021–october 2024
Table 472 Thermo Fisher Scientific Inc: Expansions, January 2021–october 2024
Table 473 Lonza: Company Overview
Table 474 Lonza: Products Offered
Table 475 Lonza: Product Launches, January 2021– October 2024
Table 476 Lonza: Deals, January 2021– October 2024
Table 477 Sartorius: Company Overview
Table 478 Sartorius Ag: Products Offered
Table 479 Sartorius Ag: Product Launches, January 2021–october 2024
Table 480 Sartorius Ag: Deals, January 2021–october 2024
Table 481 Sartorius Ag: Expansions, January 2021– October 2024
Table 482 Agilent Technologies: Company Overview
Table 483 Agilent Technologies: Products Offered
Table 484 Agilent Technologies: Product Launches, January 2021–october 2024
Table 485 Agilent Technologies: Deals, January 2021– October 2024
Table 486 Avantor: Company Overview
Table 487 Avantor: Products Offered
Table 488 Avantor: Deals, January 2021–october 2024
Table 489 Fresenius: Company Overview
Table 490 Fresenius: Products Offered
Table 491 Fresenius: Deals, January 2021–september 2024
Table 492 Bd: Company Overview
Table 493 Bd: Products Offered
Table 494 Bd: Product Launches, January 2021– October 2024
Table 495 Corning Incorporated: Company Overview
Table 496 Corning Incorporated: Products Offered
Table 497 Terumo Corporation: Company Overview
Table 498 Terumo Corporation: Products Offered
Table 499 Terumo Corporation: Product Launches, January 2021–october 2024
Table 500 Terumo Corporation: Deals, January 2021–october 2024
Table 501 Terumo Corporation: Expansions, January 2021–october 2024
Table 502 Bio-techne: Company Overview
Table 503 Bio-techne: Products Offered
Table 504 Bio-techne: Product Launches, January 2021–october 2024
Table 505 Bio-techne: Deals, January 2021–october 2024
Table 506 Bio-techne: Other Developments, January 2021–october 2024
Table 507 Genscript: Company Overview
Table 508 Genscript: Products Offered
Table 509 Genscript: Deals, January 2021–october 2024
Table 510 Maxcyte: Company Overview
Table 511 Maxcyte: Products Offered
Table 512 Maxcyte: Deals, January 2021–october 2024
Table 513 Stemcell Technologies: Company Overview
Table 514 Stemcell Technologies: Products Offered
Table 515 Stemcell Technologies: Product Launches,
January 2021– October 2024
Table 516 Stemcell Technologies: Deals, January 2021–october 2024
Figures List
Figure 1 Cell Therapy Technologies Market Segmentation And Regional Scope
Figure 2 Cell Therapy Technologies Market: Research Design
Figure 3 Cell Therapy Technologies Market: Breakdown Of Primary Interviews
Figure 4 Cell Therapy Technologies Market Size Estimation
(Supply-side Analysis), 2023
Figure 5 Market Size Estimation Approach 1
(Company Revenue Analysis-based Estimation), 2023
Figure 6 Illustrative Example Of Danaher Corporation:
Revenue Share Analysis (2023)
Figure 7 Market Size Validation From Primary Sources
Figure 8 Market Size Estimation Methodology: Top-down Approach
Figure 9 Cell Therapy Technologies Market: Cagr Projections
Figure 10 Data Triangulation Methodology
Figure 11 Cell Therapy Technologies Market, By Product,
2024 Vs. 2029 (Usd Million)
Figure 12 Cell Therapy Technologies Market, By Process,
2024 Vs. 2029 (Usd Million)
Figure 13 Cell Therapy Technologies Market, By Cell Type,
2024 Vs. 2029 (Usd Million)
Figure 14 Cell Therapy Technologies Market, By Application,
2024 Vs. 2029 (Usd Million)
Figure 15 Cell Therapy Technologies Market, By End User,
2024 Vs. 2029 (Usd Million)
Figure 16 Geographical Snapshot Of Cell Therapy Technologies Market
(2024-2029)
Figure 17 Increased Funding & Investment In Cell Therapy And
Advancements In Gene Editing Technologies To Drive Market
Figure 18 Us Accounted For Largest Market Share In 2023
Figure 19 Media, Sera, And Reagents To Dominate Market During Forecast Period
Figure 20 Apac Countries To Register Highest Cagr During Forecast Period
Figure 21 Cell Therapy Technologies Market:
Drivers, Restraints, Opportunities, And Challenges
Figure 22 Cell Therapy Technologies Market: Ecosystem
Figure 23 Average Selling Price Trend Of Cell Therapy Equipment,
2024 (Usd Thousand)
Figure 24 Cell Therapy Technologies Market: Value Chain Analysis
Figure 25 Cell Therapy Technologies Market: Overview Of Patenting Activity
Figure 26 Cell Therapy Technologies Market: Porter’s Five Forces Analysis
Figure 27 Influence Of Stakeholders On Buying Process
Figure 28 Key Buying Criteria For Top Four End Users
Figure 29 Government Funding For R&D From 2019–2024
Figure 30 Trends/Disruptions Impacting Customer Business
Figure 31 Cell Therapy Technologies Market: Impact Of Ai
Figure 32 North America: Cell Therapy Technologies Market Snapshot
Figure 33 Asia Pacific: Cell Therapy Technologies Market Snapshot
Figure 34 Revenue Analysis Of Key Players In
Cell Therapy Technologies Market, 2021–2023
Figure 35 Market Share Analysis Of Key Players In
Cell Therapy Technologies Market, 2023
Figure 36 Cell Therapy Technologies Market:
Company Evaluation Matrix (Key Players), 2023
Figure 37 Cell Therapy Technologies Market: Company Footprint
Figure 38 Cell Therapy Technologies Market:
Company Evaluation Matrix (Startups/Smes), 2023
Figure 39 Ev/Ebitda Of Key Vendors
Figure 40 Year-to-date (Ytd) Price Total Return And 5-year Stock Beta Of
Key Vendors
Figure 41 Cell Therapy Technologies Market:
Brand/Product Comparative Analysis
Figure 42 Danaher Corporation: Company Snapshot
Figure 43 Merck Kgaa: Company Snapshot
Figure 44 Thermo Fisher Scientific Inc: Company Snapshot
Figure 45 Lonza: Company Snapshot
Figure 46 Sartorius Ag: Company Snapshot
Figure 47 Agilent Technologies: Company Snapshot
Figure 48 Avantor: Company Snapshot
Figure 49 Fresenius: Company Snapshot
Figure 50 Bd: Company Snapshot
Figure 51 Corning Incorporated: Company Snapshot
Figure 52 Terumo Corporation: Company Snapshot
Figure 53 Bio-techne: Company Snapshot
Figure 54 Genscript: Company Snapshot
Figure 55 Maxcyte: Company Snapshot

1 Introduction
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Market Segmentation And Regional Scope
1.3.2 Inclusions & Exclusions
1.3.3 Years Considered
1.3.4 Currency Considered
1.4 Stakeholders
1.5 Summary Of Changes
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 Market Estimation
2.2.2 Insights From Primary Experts
2.2.3 Segmental Market Estimation (Top-down Approach)
2.3 Market Growth Rate Projections
2.4 Data Triangulation
2.5 Research Assumptions
2.6 Research Limitations
2.7 Risk Analysis
3 Executive Summary
4 Premium Insights
4.1 Cell Therapy Technologies Market Overview
4.2 North America: Cell Therapy Technologies Market,
By Product And Country (2023)
4.3 Cell Therapy Technologies Market Share, By Product, 2024 Vs. 2029
4.4 Cell Therapy Technologies Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increased Funding And Investment In Cell Therapy
5.2.1.2 Advancements In Gene Editing Technologies
5.2.1.3 Development Of Automated Cell Processing Systems
5.2.1.4 Regulatory Support For Fast-tracking Therapies
5.2.2 Restraints
5.2.2.1 Manufacturing And Logistical Complexity
5.2.3 Opportunities
5.2.3.1 Personalized And Off-the-shelf Cell Therapies
5.2.3.2 Integration With Digital Technologies Such As Ai & Ml
5.2.4 Challenges
5.2.4.1 Supply Chain & Cold Chain Management And Manufacturing Scalability & Quality Control
5.3 Ecosystem Analysis
5.3.1 Product Providers
5.3.2 End Users
5.3.3 Regulatory Bodies
5.4 Technology Analysis
5.4.1 Key Technologies
5.4.1.1 Magnetic-activated Cell Sorting
5.4.1.2 Cryopreservation
5.4.1.3 Gene Editing Technologies
5.4.1.4 Bioprocessing Technologies
5.4.2 Complementary Technologies
5.4.2.1 Artificial Intelligence And Machine Learning
5.4.2.2 Biomaterials And Scaffolding
5.4.2.3 Automation And Scalability
5.4.3 Adjacent Technologies
5.4.3.1 Nanotechnology
5.4.3.2 Immunotherapy Platforms
5.5 Pricing Analysis
5.5.1 Average Selling Price Trend Of Cell Therapy Products,
By Key Player, 2022–2024
5.5.2 Average Selling Price Trend Of Cell Therapy Equipment,
By Region, 2022–2024
5.6 Value Chain Analysis
5.7 Patent Analysis
5.8 Trade Analysis
5.8.1 Import Data For Machines And Apparatus For Electroplating, Electrolysis, Or Electrophoresis (Hs Code: 854330)
5.8.2 Export Data For Machines And Apparatus For Electroplating, Electrolysis, Or Electrophoresis (Hs Code: 854330)
5.9 Key Conferences And Events, 2025–2026
5.10 Regulatory Landscape
5.10.1 Regulatory Bodies, Government Agencies, And Other Organizations
5.10.2 Regulatory Framework
5.10.2.1 North America
5.10.2.2 Europe
5.10.2.3 Asia Pacific
5.10.2.4 Rest Of The World
5.11 Porter’s Five Forces Analysis
5.11.1 Threat Of New Entrants
5.11.2 Threat Of Substitutes
5.11.3 Bargaining Power Of Buyers
5.11.4 Bargaining Power Of Suppliers
5.11.5 Intensity Of Competitive Rivalry
5.12 Key Stakeholders And Buying Criteria
5.12.1 Key Stakeholders
5.12.2 Buying Criteria
5.13 Investment & Funding Scenario
5.14 Trends/Disruptions Impacting Customer Businesses
5.15 Impact Of Ai/Gen Ai On Cell Therapy Technologies Market
6 Cell Therapy Technologies Market, By Product
6.1 Introduction
6.2 Media, Sera, And Reagents
6.2.1 Importance Of Media, Sera, And Reagents In Cell Processing
To Drive Market
6.3 Cell Therapy Equipment
6.3.1 Cell Processing Equipment
6.3.1.1 Development Of Automated And Closed-system Cell Processing Equipment To Accelerate Segment Growth
6.3.2 Single-use Equipment
6.3.2.1 Increasing Funding For Stem Cell Therapy To Drive Market
6.3.3 Other Cell Therapy Equipment
6.4 Systems & Software
6.4.1 Rising Demand For Cell Therapies To Support Market Growth
6.5 Cell Culture Vessels
6.5.1 Rising R&D And Investments In Cell-based Therapies To
Drive Demand
6.6 Cell Engineering Products
6.6.1 Availability Of Wide Range Of Cell Engineering Products To Support Market
6.7 Other Products
7 Cell Therapy Technologies Market, By Process
7.1 Introduction
7.2 Cell Processing
7.2.1 Cell Expansion
7.2.1.1 Rising Demand For Personalized And Regenerative Therapies To
Drive Market Growth
7.2.2 Cell Isolation
7.2.2.1 Rising Need For Scalable, Efficient Isolation Technologies To
Drive Market
7.2.3 Cell Characterization
7.2.3.1 Increasing Demand For High-quality, Safe, And Effective
Cell-based Therapies To Propel Growth
7.2.4 Cell Collection
7.2.4.1 Advancements In Cell Collection Technologies To Drive Market
7.3 Cell Preservation
7.3.1 Advancement In Cryopreservation Technologies To Drive Growth
7.4 Process Monitoring & Quality Control
7.4.1 Increasing Demand For Automated Quality Control In
Cell Therapy Production To Drive Market
7.5 Cell Handling
7.5.1 Increasing Demand For Automated, Efficient,
And Scalable Solutions To Drive Market Growth
7.6 Cell Distribution
7.6.1 Increased Focus On Transportation And Storage To
Drive Market Growth
8 Cell Therapy Technologies Market, By Cell Type
8.1 Introduction
8.2 T Cells
8.2.1 Rising Research On Car T-cell Therapy To Accelerate Growth
8.3 Stem Cells
8.3.1 Increasing Funding For Stem Cell Research To Propel Market
8.4 Other Cells
9 Cell Therapy Technologies Market, By Application
9.1 Introduction
9.2 Cancer
9.2.1 Rising Research On Car T-cell Therapy To Accelerate
Segment Growth
9.3 Cardiovascular Disease
9.3.1 Increasing Focus On Innovative Cell Therapy Approaches To
Drive Market
9.4 Orthopedic Disorders
9.4.1 Increasing Focus On Stem Cell Therapy For Tissue Regeneration
To Drive Market
9.5 Autoimmune Diseases
9.5.1 Increasing Funding For Stem Cell Research To
Support Market Growth
9.6 Other Applications
10 Cell Therapy Technologies Market, By End User
10.1 Introduction
10.2 Biopharmaceutical & Biotechnology Companies
10.2.1 Increasing Adoption Of Inorganic Growth Strategies
By Biopharmaceutical Companies To Drive Market
10.3 Cros & Cmos
10.3.1 Focus On Outsourcing To Drive Segment Growth
10.4 Research Institutes
10.4.1 Rising Research Activity To Support Market Growth
10.5 Cell Banks
10.5.1 Increasing Demand For Standardized Cell Lines To
Support Market Growth
11 Cell Therapy Technologies Market, By Region
11.1 Introduction
11.2 North America
11.2.1 Macroeconomic Outlook For North America
11.2.2 Us
11.2.2.1 Us Dominates North American Cell Therapy Technologies Market
11.2.3 Canada
11.2.3.1 Increasing Government Funding To Drive Adoption Of
Cell Therapy Instruments
11.3 Europe
11.3.1 Macroeconomic Outlook For Europe
11.3.2 Germany
11.3.2.1 Germany To Hold Largest Market Share
11.3.3 Uk
11.3.3.1 Favorable Funding & Investment Scenario To Drive Market Growth
11.3.4 France
11.3.4.1 Availability Of Government & Private Funding To
Support Market Growth
11.3.5 Italy
11.3.5.1 Increasing R&D, Public & Private Investment, And Support To Offer Growth Opportunities
11.3.6 Spain
11.3.6.1 Advancement In Personalized Medicine To Stimulate Market
11.3.7 Rest Of Europe
11.4 Asia Pacific
11.4.1 Macroeconomic Outlook For Asia Pacific
11.4.2 China
11.4.2.1 Increasing R&D Expenditure To Drive Market Growth
11.4.3 Japan
11.4.3.1 Strong Availability Of Funding To Support Market Growth
11.4.4 India
11.4.4.1 Rising Funding Programs To Drive Market
11.4.5 Australia
11.4.5.1 Increasing Government Funding & Initiatives To Drive Market Growth
11.4.6 South Korea
11.4.6.1 Alliances & Investments In Research To Drive Market
11.4.7 Rest Of Asia Pacific
11.5 Latin America
11.5.1 Macroeconomic Outlook For Latin America
11.5.2 Brazil
11.5.2.1 Brazil To Dominate Latin American Market Till 2029
11.5.3 Mexico
11.5.3.1 Strong Pharmaceutical Industry And Increased Government Support To Augment Market
11.5.4 Rest Of Latin America
11.6 Middle East
11.6.1 Macroeconomic Outlook For Middle East
11.6.2 Gcc Countries
11.6.2.1 Saudi Arabia
11.6.2.1.1 Increasing Government Investments In Healthcare And Growing Pharmaceuticals Industry To Support Market
11.6.2.2 Uae
11.6.2.2.1 Growing R&D Expenditure & Well-established Class Infrastructure To Drive Market
11.6.2.3 Rest Of Gcc Countries
11.6.3 Rest Of Middle East
11.7 Africa
11.7.1 Macroeconomic Outlook For Africa
12 Competitive Landscape
12.1 Overview
12.2 Key Player Strategies/Right To Win
12.2.1 Overview Of Strategies Adopted By Players In Cell Therapy Technologies Market
12.3 Revenue Analysis
12.4 Market Share Analysis
12.5 Company Evaluation Matrix: Key Players, 2023
12.5.1 Stars
12.5.2 Emerging Leaders
12.5.3 Pervasive Players
12.5.4 Participants
12.5.5 Company Footprint: Key Players, 2023
12.5.5.1 Company Footprint
12.5.5.2 Region Footprint
12.5.5.3 Product Footprint
12.5.5.4 Process Footprint
12.5.5.5 Cell Type Footprint
12.5.5.6 Application Footprint
12.6 Company Evaluation Matrix: Startups/Smes, 2023
12.6.1 Progressive Companies
12.6.2 Responsive Companies
12.6.3 Dynamic Companies
12.6.4 Starting Blocks
12.6.5 Competitive Benchmarking: Startups/Smes, 2023
12.7 Company Valuation & Financial Metrics
12.7.1 Financial Metrics
12.7.2 Company Valuation
12.8 Brand/Product Comparison
12.9 Competitive Scenario
12.9.1 Product Launches
12.9.2 Deals
12.9.3 Expansions
13 Company Profiles
13.1 Key Players
13.1.1 Danaher Corporation
13.1.1.1 Business Overview
13.1.1.2 Products Offered
13.1.1.3 Recent Developments
13.1.1.3.1 Product Launches
13.1.1.3.2 Deals
13.1.1.3.3 Expansions
13.1.1.4 Mnm View
13.1.1.4.1 Key Strengths
13.1.1.4.2 Strategic Choices
13.1.1.4.3 Weaknesses And Competitive Threats
13.1.2 Merck Kgaa
13.1.2.1 Business Overview
13.1.2.2 Products Offered
13.1.2.3 Recent Developments
13.1.2.3.1 Deals
13.1.2.3.2 Expansions
13.1.2.4 Mnm View
13.1.2.4.1 Key Strengths
13.1.2.4.2 Strategic Choices
13.1.2.4.3 Weaknesses And Competitive Threats
13.1.3 Thermo Fisher Scientific Inc.
13.1.3.1 Business Overview
13.1.3.2 Products Offered
13.1.3.3 Recent Developments
13.1.3.3.1 Product Launches
13.1.3.3.2 Deals
13.1.3.3.3 Expansions
13.1.3.4 Mnm View
13.1.3.4.1 Key Strengths
13.1.3.4.2 Strategic Choices
13.1.3.4.3 Weaknesses And Competitive Threats
13.1.4 Lonza
13.1.4.1 Business Overview
13.1.4.2 Products Offered
13.1.4.3 Recent Developments
13.1.4.3.1 Product Launches
13.1.4.3.2 Deals
13.1.5 Sartorius Ag
13.1.5.1 Business Overview
13.1.5.2 Products Offered
13.1.5.3 Recent Developments
13.1.5.3.1 Product Launches
13.1.5.3.2 Deals
13.1.5.3.3 Expansions
13.1.6 Agilent Technologies, Inc.
13.1.6.1 Business Overview
13.1.6.2 Products Offered
13.1.6.3 Recent Developments
13.1.6.3.1 Product Launches
13.1.6.3.2 Deals
13.1.7 Avantor, Inc.
13.1.7.1 Business Overview
13.1.7.2 Products Offered
13.1.7.3 Recent Developments
13.1.7.3.1 Deals
13.1.8 Fresenius Se & Co. Kgaa
13.1.8.1 Business Overview
13.1.8.2 Products Offered
13.1.8.3 Recent Developments
13.1.8.3.1 Deals
13.1.9 Becton, Dickinson And Company
13.1.9.1 Business Overview
13.1.9.2 Products Offered
13.1.9.3 Recent Developments
13.1.9.3.1 Product Launches
13.1.10 Corning Incorporated
13.1.10.1 Business Overview
13.1.10.2 Products Offered
13.1.11 Terumo Corporation
13.1.11.1 Business Overview
13.1.11.2 Products Offered
13.1.11.3 Recent Developments
13.1.11.3.1 Product Launches
13.1.11.3.2 Deals
13.1.11.3.3 Expansions
13.1.12 Bio-techne
13.1.12.1 Business Overview
13.1.12.2 Products Offered
13.1.12.3 Recent Developments
13.1.12.3.1 Product Launches
13.1.12.3.2 Deals
13.1.12.3.3 Other Developments
13.1.13 Genscript
13.1.13.1 Business Overview
13.1.13.2 Products Offered
13.1.13.3 Recent Developments
13.1.13.3.1 Deals
13.1.14 Maxcyte
13.1.14.1 Business Overview
13.1.14.2 Products Offered
13.1.14.3 Recent Developments
13.1.14.3.1 Deals
13.1.15 Stemcell Technologies
13.1.15.1 Business Overview
13.1.15.2 Products Offered
13.1.15.3 Recent Developments
13.1.15.3.1 Product Launches
13.1.15.3.2 Deals
13.2 Other Players
13.2.1 Oxford Biomedica Plc
13.2.2 Roosterbio, Inc.
13.2.3 Trakcel
13.2.4 L7 Informatics, Inc.
13.2.5 Miltenyi Biotec
13.2.6 Repligen Corporation
13.2.7 Mak System
13.2.8 Origen Biomedical, Inc.
13.2.9 Ixcells Biotechnologies
13.2.10 Körber Ag
14 Appendix
14.1 Discussion Guide
14.2 Knowledgestore: Marketsandmarkets’ Subscription Portal
14.3 Customization Options
14.4 Related Reports
14.5 Author Details

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings